ONCE-DAILY TIOTROPIUM RESPIMAT®: SAFETY AND TOLERABILITY RESULTS FROM FIVE PHASE III TRIALS IN ADULTS WITH SYMPTOMATIC ASTHMA: Abstract ID – 589


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles